ArticleFrontiers in medicine2023

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review.

Carla Sans-Pola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.